Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TAVALISSE® safely and effectively. See full prescribing information for TAVALISSE. TAVALISSE® (fostamatinib disodium hexahydrate) tablets, for oral useInitial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
TAVALISSE is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.
- generic_name
- fostamatinib
- product_names
- FOSTAMATINIB
- ndc
- 71332-001, 71332-002, 71332-001-01, 71332-002-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en